GOELTZ II ROBERT C. (Chief Financial Officer) sold 8.8% of their position (6.55K shares) of ARCUS BIOSCIENCES, INC. on the open market
Open‑market sale worth $153.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/2/2026ACC: 0001610717-26-000002
Officer· Chief Financial Officer
Since Aug 2020
-6.55K
Net shares
Net seller
$153.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
6.55K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−6.55K
Price / share
$23.38
Trade value
$153.19K
% of position
8.8%
12/31/2025
74.48K→67.92K
Total
Net shares
−6.55K
Net value
-$153.19K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/31/2025 | S · Sale | −6.55K | $23.38 | $153.19K | 8.8% | 74.48K | 67.92K |
| Total | −6.55K | -$153.19K | ||||||
Derivative Transactions0
No derivative transactions reported